Drug profile · INN
formoterol (fumarate)
ZENHALE
formoterol (fumarate) (ZENHALE) is a beta-2 adrenergic receptor agonist.
EMA: application withdrawn Respiratory system (R03) R03AK07
Patents linked 2
Pipeline programs 7
News articles 0
Drug details — formoterol (fumarate)
- Class
- Respiratory system (R03)
- Route
- —
- Patents
- 2
- Programs
- 7
- Data quality
- 0.83
Quick answer
formoterol (fumarate) (ZENHALE) is a beta-2 adrenergic receptor agonist.
Key facts
INN formoterol (fumarate)
Brand ZENHALE
Mechanism Beta-2 adrenergic receptor agonist
Target Beta-2 adrenergic receptor
Therapeutic class Respiratory system (R03)
ATC code R03AK07
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is formoterol (fumarate)?
formoterol (fumarate) (ZENHALE) is a beta-2 adrenergic receptor agonist.
What is the brand name for formoterol (fumarate)?
ZENHALE is a marketed brand name for formoterol (fumarate). Check FDA Drugs@FDA for the current US label holder and prescribing information.